drugset
drugset / Trial / NCT00070707

Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280)

NCT00070707 ↗

Phase 4 Completed 188 enrolled Organon and Co Integrated Therapeutics Group · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

This study will compare mometasone nasal spray to placebo in treating the nasal and asthma symptoms experienced by participants with seasonal allergic rhinitis (SAR) and concomitant asthma.

Timeline

Start
2003-04-03
Primary completion
2003-11-26
Completion
2003-11-26

Outcome

Missed primary endpoint

registry analysis (unspecified test); Mometasone vs Placebo; p = 0.101; ANOVA NCT00070707 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Mometasone Other / unclassified 200 ug Intranasal
Background Salbutamol Unknown 90 ug Inhaled

Indications

asthma seasonal allergic rhinitis